Chemical Biology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
Jack H. Skirball Center for Chemical Biology and Proteomics, The Salk Institute, La Jolla, CA, USA
Department of Chemistry, Harvard University, Cambridge, MA, USA
In addition to NMDA receptor antagonism, ketamine also inhibits pentameric ligand-gated ion channels (pLGICs). The molecular mechanism is an active area of investigation, and one method for accessing molecular mechanisms is to use computational approaches...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
3 Recommendations, most recent by| Interesting Hypothesis | New Finding | Novel Drug Target | Technical Advance
Past 7 Days
New Articles Recommended
Past 30 Days
27Articles Classified As Technical Advance8,746 total
10Articles Classified As Confirmation2,800 total
12Articles Classified As Novel Drug Target2,950 total
1Articles Classified As Controversial1,024 total
43Articles Classified As New Finding16,777 total
23Articles Classified As Good for Teaching1,785 total
6Articles Classified As Review / Commentary791 total
11Articles Classified As Interesting Hypothesis4,531 total
Get instant access to Article Recommendations from more than 8,000 leading experts in Biology and Medicine by taking out a monthly subscription.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.